- Kefalogianni M., Mouchliadis L., Stratakis E. and Psilodimitrakopoulos S. (2026) Shell–Core Structural Anisotropy in Starch Granules Probed by Polarization Third-Harmonic Generation Microscopy. Photonics 13, 16, DOI: 10.3390/photonics13010016
- Tsagkari D., Markaki M. and Tavernarakis N. (2025) NHR-85 modulates mitochondrial and lipid homeostasis to protect against α-synuclein aggregation in C. elegans. Journal of Cell Science, 138: jcs263651.
- Mavroeidi P. and Xilouri M. (2025) Autophagy–Lysosome Pathway in Multiple System Atrophy Pathogenesis: The Best Is Yet to Come. Int. J. Mol. Sci., 26, 10204, DOI: 10.3390/ijms262010204
- Vekrellis K., Lamprokostopoulou A., Melachroinou K., Kokoli M., Zingkou E., Skarveli M., Kolianou A., Samiotaki M. and Sotiropoulou G. (2025) Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation. NPJ Parkinson’s Disease, 11:277, DOI: 10.1038/s41531-025-01122-9
- Fouka M., Tsakogias I., Gialinaki E.-G., Stavropoulos A., Volbracht C., De Muynck V., Moechars D., Melki R., Tofaris G.K., Stefanis L. and Xilouri M. (2025) In vivo validation of novel non-invasive PHP. eB AAVs as a potential therapeutic approach for alpha-synucleinopathies. Acta Neuropathologica Communications, 13:207, DOI: 10.1186/s40478-025-02121-w
- Kaur A., Babaliari E., Bolanos-Garcia V.M., Kefalogianni M., Psilodimitrakopoulos S., Kavatzikidou P., Ranella A., Ghorbani M., Stratakis E., Eskin D.G. & Tzanakis I. (2025) Assessment of aqueous graphene as a cancer therapeutics delivery system. Scientific Reports, 15:15396, DOI: 10.1038/s41598-025-98406-0
- Tsagkari D., Panagiotidou E. and Tavernarakis N. (2025) The role of lipid metabolism in neuronal senescence. FEBS Open Bio, DOI: 10.1002/2211-5463.70181
- Kounakis K., Layana Castro P. E., Garcia Garvi A., Sanchez-Salmeron A.-J. and Tavernarakis N. (2025) Automated analysis of C. elegans fluorescence images using SegElegans. Journal of Visualized Experiments, 224: e69094.
- Georgoulakis M., Angelonidis I., Froudas K.G., Eleftheriadis N. and Neochoritis C.G. (2025) Privileged scaffolds on demand: a Passerini-based strategy toward α-ketoamides. Org. Biomol. Chem., DOI: 10.1039/d5ob01629k
- Somaraki M., Zachilas I., Tsapinou E., Boulkou G., Montagnon T., Vassilikogiannakis G. and Eleftheriadis N. (2025) Activating human 15-lipoxygenase-1 beyond flatland: discovery of non-aromatic modulators. Org. Biomol. Chem., DOI: 10.1039/d5ob00820d
- Adamis K.S., Georgoulakis M., Angelonidis I., Korovesis D., Papadopoulos C., Kapsalis M., Tavernarakis N., Eleftheriadis N. and G. Neochoritis C.G. (2025) The Evolution of Fluorescein into A Potential Theranostic Tool. Chem. Eur. J., 0, e202501513, DOI: 10.1002/chem.202501513
- Foukarakis I., Sampatakakis S, Mamalaki E., Kyrozis A., Ntanasi E., Tsapanou A., Yannakoulia M., Rouskas K. and Nikolaos Scarmeas N. (2025) Sleep architecture in Alzheimer’s disease continuum: The deep sleep question. Open Life Sciences; 20: 20251077, DOI: 10.1515/biol-2025-1077
- Bourboula A., Mantzourani C., Chalatsa I., Machalia C., Emmanouilidou E., Kokotou M.G. and Kokotos G. (2025) A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A2 Inhibitors. Biomolecules, 15, 626, DOI: 10.3390/biom15050626
- Koros C., Simitsi A.-M., Papagiannakis N., Antonelou R., Bougea A., Papadimitriou D., Pachi I., Beratis I., Kontaxopoulou D., Fragkiadaki S., Sfikas E., Alefanti I., Chrysovitsanou C., Angelopoulou E., Bregianni M., Lourentzos K., Constantinides V.C., Velonakis G., Prassopoulos V., Bonakis A., Papageorgiou S.G., Potagas C., Picillo M., Barone P., Stamelou M. and Stefanis L. (2025) Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein carriers. Parkinsonism and Related Disorders, 135, 107853, DOI: 10.1016/j.parkreldis.2025.107853
- Liakakis G., Vakrakou A.G., Boufidou F., Constantinides V., Velonakis G., Paraskevas G.P., Stefanis L. and Kapaki E. (2025) Exploratory Analysis of Cerebrospinal Fluid IL-6 and IL-17A Levels in Subcortical Small-Vessel Disease Compared to Alzheimer’s Disease: A Pilot Study. Diagnostics, 15, 669, DOI: 10.3390/diagnostics15060669
- Dimoula K., Papagiannakis N., Maniati M., Stefanis L. and Emmanouilidou E. (2025) Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson’s Disease. Parkinsonism and Related Disorders, 133, 107321, DOI: 10.1016/j.parkreldis.2025.107321
- Louka A., Spacho N., Korovesis D., Adamis K., Papadopoulos C., Kalaitzaki E.-E., Tavernarakis N., Neochoritis C.G. and Eleftheriadis N. (2025) Crafting Molecular Tools for 15-Lipoxygenase-1 in a Single Step. Angewandte Chemie, 64: e202418291
- Karavasilis E., Balomenos V., Christidi F., Velonakis G., Angelopoulou G., Yannakoulia M., Mamalaki E., Drouka A., Brikou D., Tsapanou A., Gu Y. and Scarmeas N. (2024) Mediterranean diet and brain functional connectivity in a population without dementia. Frontiers in Neuroimaging, DOI: 10.3389/fnimg.2024.1473399
- Alefanti I., Koros C., Tsami V., Simitsi A.-M., Chrisoula Kartanou C., Papagiannakis N., Bozi M., Antonelou R., Maniati M., Hauser A.-K., Varvaressos S., Bonakis A., Lourentzos K., Makrythanasis P., Papageorgiou S.G., Proukakis C., Potagas C., Gasser T., Koutsis G., Karadima G. and Stefanis L (2024) The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's disease. Eur J Neurol.;32: e16562, DOI: 10.1111/ene.16562
- Theodoropoulou M.A., Mantzourani C. and Kokotos G. (2024) Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases, Biomolecules, 14, 1605. DOI:10.3390/biom14121605
- Tiwari V., Buvarp E., Borbolis F., Puligilla C., Croteau D.L., Palikaras K. and Bohr V.A. (2024) Loss of DNA glycosylases improves health and cognitive function in a C. elegans model of human tauopathy. Nucleic Acids Research, 52, 10965–10985, DOI:10.1093/nar/gkae705
- Vekrellis K., Emmanouilidou E., Xilouri M. and Stefanis L. (2024) α-Synuclein in Parkinson’s Disease: 12 Years Later. Cold Spring Harb Perspect Med, DOI: 10.1101/cshperspect.a041645
- Christidi F., Drouka A., Brikou D., Mamalaki E., Ntanasi E., Karavasilis E., Velonakis G., Angelopoulou G., Tsapanou A., Gu Y., Yannakoulia M.and Scarmeas N. (2024) The Association between Individual Food Groups, Limbic System White Matter Tracts, and Episodic Memory: Initial Data from the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study. Nutrients, 16, 2766, DOI: 10.3390/nu16162766
- Spacho N., Casertano M., Imperatore C., Papadopoulos C., Menna M. and Eleftheriadis N. (2024) Investigating the Catalytic Site of Human 15-Lipoxygenase- 1 via Marine Natural Products. Chem. Eur. J. e202402279, DOI: 10.1002/chem.202402279
- Giotas E., Kaplani S.-A. and Eleftheriadis N. (2024) The Multifunctional Preprotein Binding Domain of SecA. ChemBioChem, e202400621, DOI: 10.1002/cbic.202400621
- Chalkiadaki K., Statoulla E., Zafeiri M., Voudouri G., Amvrosiadis T., Typou A., Theodoridou N., Moschovas D., Avgeropoulos A., Samiotaki M., Mason J.O. and Gkogkas C.G. (2024) GABA/Glutamate Neuron Differentiation Imbalance and Increased AKT/mTOR Signaling in CNTNAP22/2 Cerebral Organoids. Biol Psychiatry Glob Open Sci., DOI: 10.1016/j.bpsgos.2024.100413
ΣχετικΑ
«Εμβληματικές δράσεις σε διαθεματικές επιστημονικές περιοχές με ειδικό ενδιαφέρον για την σύνδεση με τον παραγωγικό ιστό»
Κωδικός Αίτησης: TAEDR-0535850
Η δράση υλοποιείται στο πλαίσιο του Εθνικού Σχεδίου Ανάκαμψης και Ανθεκτικότητας Ελλάδα 2.0 «Με τη Χρηματοδότηση της Ευρωπαϊκής Ένωσης – NextGenerationEU»
ΣΥΝΔΕΣΜΟΙ



ΓΕΝΙΚΗ ΓΡΑΜΜΑΤΕΙΑ ΕΡΕΥΝΑΣ ΚΑΙ ΚΑΙΝΟΤΟΜΙΑΣ
ΥΠΟΥΡΓΕΙΟ ΑΝΑΠΤΥΞΗΣ
«Εμβληματικές δράσεις σε διαθεματικές επιστημονικές περιοχές με ειδικό ενδιαφέρον για την σύνδεση με τον παραγωγικό ιστό»
Ανάδειξη, επιβεβαίωση και αξιοποίηση της γενετικής βάσης μη-μεταδοτικών πολυπαραγοντικών νοσημάτων για την ανάπτυξη νέων θεραπευτικών προσεγγίσεων και αξιόπιστων βιοδεικτών
Φορέας Υλοποίησης Υπουργείο Οικονομικών,
Ειδική Υπηρεσία Συντονισμού Ταμείου Ανάκαμψης
Ειδική Υπηρεσία Συντονισμού Ταμείου Ανάκαμψης